Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Glaukos (NYSE:GKOS) in the last three months. The table below provides a snapshot of their ...
Glaukos Co. (NYSE:GKOS – Get Free Report) was up 5.4% during mid-day trading on Wednesday after Wells Fargo & Company raised their price target on the stock from $145.00 to $153.00.Wells Fargo ...
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback